Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2021 | The impact of age on COVID-19 outcomes in patients

Lisa Hicks • 16 Dec 2021
ASH 2021
General

Lisa Hicks, MD, MSc, St. Michael’s Hospital, Toronto, Canada, discusses the role age plays in determining COVID-19 outcomes and treatment patterns in patients with hematologic malignancies. Analysis from the ASH Research Collaborative (RC) COVID-19 Registry for Hematology revealed that the rate of symptomatic and asymptomatic cancer was similar across age ranges, with reported symptoms including fever, coughing, and shortness of breath being consistent across patients. However, the presence of co-morbidities was increased in older patients and when taking into account gender, younger women tended to fare better, whilst older men had inferior outcomes. This interview took place at the 63rd ASH Annual Meeting and Exposition congress in Atlanta, GA.

More from Lisa Hicks

COVID-19-related risk factors in patients with blood cancers
4:55
COVID-19-related risk factors in patients with blood cancers
Lisa Hicks • 16 Dec 2021
COVID-19 risk factors in patients with hematologic malignancies
4:45
COVID-19 risk factors in patients with hematologic malignancies
Lisa Hicks • 11 Dec 2021

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals